PAR paradigm biopharmaceuticals limited..

Ann: March 2025 Quarterly Activities Report & Appendix 4C, page-15

  1. 120 Posts.
    lightbulb Created with Sketch. 14
    My best mate informed me last we of the fact that he was informed that he had received Zilusol and not placebo in the Ph2 trial. He was sure he had given the relief gained but nonetheless good to have this confirmed.Whar shocked him was my news on the share price which he guessed must have made me a rich man and might be about to finance more comfortable fishing trips (especially given his knees). I keep faith that PARs finances will hold somehow and we get through this cashflow issue. We know it works and I feel we have a great shot at proving this ifwe can just hold out for the finish line. six years without selling a share and I honestly can't see myself being able to do this whilst the trials still run and we remain listed.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $112.9M
Open High Low Value Volume
29.5¢ 31.0¢ 28.5¢ $431.5K 1.469M

Buyers (Bids)

No. Vol. Price($)
3 21578 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 9000 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.